Header Logo

Peter J.Miller MD

TitleAssistant Professor
InstitutionWake Forest School of Medicine
DepartmentInternal Medicine, Pulmonary, Critical Care, Allergy and Immunologic Diseases
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionWake Forest School of Medicine
    DepartmentAnesthesiology

    TitleAssistant Professor
    InstitutionWake Forest School of Medicine
    DepartmentInternal Medicine, Hematology & Oncology


    Collapse Biography 
    Collapse education and training
    Albany Medical Center Hospital, Albany, NY06/2011Combined Internal Medicine/Pediatrics
    Wake Forest School of Medicine/Wake Forest Baptist Health, Winston-Salem, NC06/2014Hematology
    Wake Forest School of Medicine/Wake Forest Baptist Health, Winston-Salem, NC06/2015Critical Care Medicine
    Collapse awards and honors
    2015Winston <40 Leadership Award

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Schertz AR, Sarma AK, Datar S, Miller PJ. Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion. BMJ Case Rep. 2021 Jan 28; 14(1). PMID: 33509852.
      Citations:    
    2. Maslonka MA, Schertz AR, Markowski LM, Miller PJ. Sedation challenges in patients with E-cigarette, or vaping, product use-associated lung injury (EVALI). BMJ Case Rep. 2020 Sep 02; 13(9). PMID: 32878850.
      Citations:    
    3. Bonnecaze AK, Wilson MW, Dharod A, Fletcher A, Miller PJ. Acute kidney injury is common with intravenous abuse of extended-release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO staging. Nephrology (Carlton). 2018 Oct; 23(10):921-926. PMID: 28802086.
      Citations:    
    4. Fernando RJ, Farmer BE, Augoustides JG, Gardner JC, Johnson SD, Ha B, Friess JO, Luedi MM, Erdoes G, Miller PJ, Ripat C, Fabbro M. Perioperative Management of Mild Hemophilia B During and After Coronary Artery Bypass Grafting: Challenges and Solutions. J Cardiothorac Vasc Anesth. 2019 02; 33(2):549-555. PMID: 30177475.
      Citations:    
    5. Aseem F, Zamora BG, Kauffman L, Miller PJ, John VJ. Bilateral exudative retinal detachments due to thrombotic microangiopathy associated with intravenous abuse of Opana ER. Am J Ophthalmol Case Rep. 2018 Sep; 11:72-74. PMID: 29998206.
      Citations:    
    6. Kuhlman P, Miller P, Farland A, Owen J, Batt K. Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): Could this be a new predictive biomarker in TTP? J Clin Apher. 2018 Aug; 33(4):541-545. PMID: 29572925.
      Citations:    
    7. Wilson MW, Bonnecaze AK, Dharod A, Miller PJ. Analysis of Intensive Care Unit Admission and Sequelae in Patients Intravenously Abusing Extended-Release Oral Oxymorphone. South Med J. 2017 03; 110(3):217-222. PMID: 28257549.
      Citations:    
    8. Hunt R, Yalamanoglu A, Tumlin J, Schiller T, Baek JH, Wu A, Fogo AB, Yang H, Wong E, Miller P, Buehler PW, Kimchi-Sarfaty C. A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER. Blood. 2017 02 16; 129(7):896-905. PMID: 27864296.
      Citations:    
    9. Bonnecaze AK, Stephens SE, Miller PJ. Non-lethal Clostridium sordellii bacteraemia in an immunocompromised patient with pleomorphic sarcoma. BMJ Case Rep. 2016 Aug 03; 2016. PMID: 27489063.
      Citations:    
    10. Miller PJ, Farland AM, Knovich MA, Batt KM, Owen J. Successful treatment of intravenously abused oral Opana ER-induced thrombotic microangiopathy without plasma exchange. Am J Hematol. 2014 Jul; 89(7):695-7. PMID: 24668845.
      Citations:    
    Miller's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (78)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (58)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _